Sphingolipid-derived pharmaceutical compositions

US7629385B2 · kind B2 · utility

Assignees

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US
• Technische Universitaet Dresden · DE
• Jado Technologies GmbH · DE

Inventors

• Tobias Braxmeier · Gaggenau, DE
• Tim Friedrichson · Dresden, DE
• Wolfgang Fröhner · Walldorf, DE
• Gary Jennings · Dresden, DE
• Georg Schlechtingen · Dresden, DE
• Cornelia Schroeder · Berlin, DE
• Hans-Joachim Knolker · Dresden, DE
• Kai Simons · Dresden, DE
• Marino Zerial · Dresden, DE
• Teymuras Kurzchalia · Berlin, DE

Key dates

• Filing date: Jun 29, 2005
• Grant date: Dec 8, 2009
• Expiry date: Jul 11, 2025

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to specific sphingolipids/sphingolipid derivatives as pharmaceutical compositions as well as their use in the preparation of medicaments for the treatment, prevention and/or amelioration of disorders relating to pathological processes in lipid rafts.